1. Национальные клинические рекомендации (издание ВНОК). М.: Силицея-Полиграф, 2009.
2. O'Brien E, Waeber B, Parati G et al. Blood pressure measuring devices: recommendations of European Society of Hypertension. BMJ 2001; 322: 531–6.
3. Asmar R, Zanchetti A, on behalf of the Organizing Committee and participants. Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Hypertens 2000; 18: 493–508.
4. Parati G, Pickering TG. Home blood-pressure monitoring: US and European consensus. Lancet 2009; 373: 876–8.
5. Staessen J, Thijs L and the participants of the First International Consensus Conference on Blood Pressure Self-Measurement. Blood Press Monit 2000; 5 (2): 101–9.
6. Ощепкова Е.В., Цагареишвили Е.В., Рогоза А.Н. Метод самоконтроля артериального давления (возможности и ограничения). Cons. Med. 11 (8): 52–5.
7. O'Brien E, Pickering Th, Asmar R et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002; 7: 3–17.
8. Association for the Advancement of Medical Instrumentation. American National Standards for Electric or Automated Sphygmomanometers. Washington, DC: AAMI. 1987.
9. Verdecchia P, O'Brien E, Pickering T et al. When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure monitoring of the European Society of Hypertension. Am J Hypertens 2003; 16 (1): 87–91.
10. Рогоза А.Н. Приборы для неинвазивного измерения артериального давления. Рус. мед. журн. 2005; 19 (13): 1226–31.
11. Yarows SA. Comparison of the Omron HEM-637 wrist monitor to the auscultation method with the wrist position sensor on or disabled. Am J Hypertens 2004; 1 (17): 54–8.
12. Anttijula S, Aari TK et al. Digitaaliset olkavarsimittarit. Verenpainemittareiden jako kahteen. Tekniikan Maailma 2003; 8: 126–36.
13. Mengden T, Battig B, Vetter W. Self-measurement of blood pressure improves the accuracy and reduces the number of subjects in clinical trials. J Hypertens 1991; 9 (Suppl. 6): 336–7.